<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=TORCH_infections</id>
	<title>TORCH infections - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=TORCH_infections"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=TORCH_infections&amp;action=history"/>
	<updated>2026-04-19T21:22:51Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=TORCH_infections&amp;diff=389321&amp;oldid=prev</id>
		<title>Danbot: Strip excess bold</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=TORCH_infections&amp;diff=389321&amp;oldid=prev"/>
		<updated>2026-03-22T09:32:42Z</updated>

		<summary type="html">&lt;p&gt;Strip excess bold&lt;/p&gt;
&lt;a href=&quot;//wikem.org/w/index.php?title=TORCH_infections&amp;amp;diff=389321&amp;amp;oldid=386205&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=TORCH_infections&amp;diff=386205&amp;oldid=prev</id>
		<title>Danbot: Moved intro paragraph into Background as bullets; removed excessive bold from bullet lead-ins; bold retained for critical items only</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=TORCH_infections&amp;diff=386205&amp;oldid=prev"/>
		<updated>2026-03-19T14:18:51Z</updated>

		<summary type="html">&lt;p&gt;Moved intro paragraph into Background as bullets; removed excessive bold from bullet lead-ins; bold retained for critical items only&lt;/p&gt;
&lt;a href=&quot;//wikem.org/w/index.php?title=TORCH_infections&amp;amp;diff=386205&amp;amp;oldid=386158&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=TORCH_infections&amp;diff=386158&amp;oldid=prev</id>
		<title>Ostermayer: Created page with &quot;TORCH infections is an acronym for a group of congenital and perinatal infections that share overlapping clinical features in the newborn: '''T'''oxoplasmosis, '''O'''ther (syphilis, varicella, parvovirus B19, Zika), '''R'''ubella, '''C'''ytomegalovirus (CMV), and '''H'''erpes simplex virus (HSV).&lt;ref name=&quot;StatPearls&quot;&gt;Jaan A, Rajnik M. TORCH Complex. ''StatPearls''. NCBI. 2023.&lt;/ref&gt; These infections account for approximately 2-3% of all congenital anomalies and may cau...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=TORCH_infections&amp;diff=386158&amp;oldid=prev"/>
		<updated>2026-03-18T00:47:40Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;TORCH infections is an acronym for a group of congenital and perinatal infections that share overlapping clinical features in the newborn: &amp;#039;&amp;#039;&amp;#039;T&amp;#039;&amp;#039;&amp;#039;oxoplasmosis, &amp;#039;&amp;#039;&amp;#039;O&amp;#039;&amp;#039;&amp;#039;ther (syphilis, varicella, parvovirus B19, Zika), &amp;#039;&amp;#039;&amp;#039;R&amp;#039;&amp;#039;&amp;#039;ubella, &amp;#039;&amp;#039;&amp;#039;C&amp;#039;&amp;#039;&amp;#039;ytomegalovirus (CMV), and &amp;#039;&amp;#039;&amp;#039;H&amp;#039;&amp;#039;&amp;#039;erpes simplex virus (HSV).&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;&amp;gt;Jaan A, Rajnik M. TORCH Complex. &amp;#039;&amp;#039;StatPearls&amp;#039;&amp;#039;. NCBI. 2023.&amp;lt;/ref&amp;gt; These infections account for approximately 2-3% of all congenital anomalies and may cau...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;TORCH infections is an acronym for a group of congenital and perinatal infections that share overlapping clinical features in the newborn: '''T'''oxoplasmosis, '''O'''ther (syphilis, varicella, parvovirus B19, Zika), '''R'''ubella, '''C'''ytomegalovirus (CMV), and '''H'''erpes simplex virus (HSV).&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;&amp;gt;Jaan A, Rajnik M. TORCH Complex. ''StatPearls''. NCBI. 2023.&amp;lt;/ref&amp;gt; These infections account for approximately 2-3% of all congenital anomalies and may cause fetal death, prematurity, growth restriction, and devastating multisystem disease.&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt; The emergency physician's role is to '''recognize the nonspecific clinical pattern''' that suggests congenital infection, '''initiate time-sensitive empiric treatment''' (especially acyclovir for HSV), and '''arrange appropriate confirmatory testing and specialist consultation'''.&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
*TORCH infections are transmitted from mother to fetus/neonate via:&lt;br /&gt;
**'''Transplacental''' (during pregnancy) — most TORCH agents&lt;br /&gt;
**'''Peripartum''' (during delivery) — HSV (~85% of neonatal HSV cases), HIV&lt;br /&gt;
**'''Postpartum''' (breast milk, close contact) — CMV, HIV&lt;br /&gt;
*'''Earlier gestational infection generally causes more severe fetal damage'''; later infection causes higher transmission rates but often milder disease&amp;lt;ref name=&amp;quot;AMBOSS&amp;quot;&amp;gt;Congenital TORCH infections. ''AMBOSS''. 2024.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Neonatal cholestasis occurs in ~1 in 2,500 live births; infections account for ~11% of cases (see [[Neonatal hepatitis]])&amp;lt;ref name=&amp;quot;Gottesman&amp;quot;&amp;gt;Gottesman LE, et al. Etiologies of conjugated hyperbilirubinemia in infancy: systematic review. ''BMC Pediatr''. 2015;15:192.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===The &amp;quot;TORCH titer&amp;quot; — limitations===&lt;br /&gt;
*A blanket &amp;quot;TORCH titer&amp;quot; panel (IgG screening) is of '''limited clinical utility''' and is '''not recommended as a primary diagnostic strategy'''&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;br /&gt;
*Neonatal IgG largely reflects '''maternal antibodies''' transferred across the placenta and does not confirm neonatal infection&lt;br /&gt;
*'''Pathogen-specific testing''' (IgM, PCR) directed by clinical suspicion is far more useful&lt;br /&gt;
*If clinical syndrome suggests congenital infection, '''investigate each pathogen individually''' with the most appropriate rapid diagnostic test&lt;br /&gt;
&lt;br /&gt;
==Clinical features==&lt;br /&gt;
===Shared/overlapping features (the congenital infection pattern)===&lt;br /&gt;
*'''Intrauterine growth restriction (IUGR)/small for gestational age'''&lt;br /&gt;
*'''Hepatosplenomegaly'''&lt;br /&gt;
*'''Jaundice''' (conjugated hyperbilirubinemia — see [[Neonatal hepatitis]])&lt;br /&gt;
*'''Petechiae, purpura, or thrombocytopenia''' (&amp;quot;blueberry muffin&amp;quot; rash — dermal erythropoiesis)&lt;br /&gt;
*'''Microcephaly'''&lt;br /&gt;
*'''Chorioretinitis'''&lt;br /&gt;
*'''Sensorineural hearing loss'''&lt;br /&gt;
*'''Intracranial calcifications'''&lt;br /&gt;
*'''Anemia'''&lt;br /&gt;
*'''Seizures'''&lt;br /&gt;
&lt;br /&gt;
Many neonates with congenital infection are '''asymptomatic at birth''' but develop sequelae (hearing loss, developmental delay, chorioretinitis) weeks to years later.&amp;lt;ref name=&amp;quot;AMBOSS&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Pathogen-specific features===&lt;br /&gt;
&lt;br /&gt;
====Toxoplasmosis (''Toxoplasma gondii'')====&lt;br /&gt;
*Classic triad: '''chorioretinitis + hydrocephalus + diffuse intracranial calcifications'''&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;br /&gt;
*Calcifications tend to be '''diffuse/scattered''' (compare CMV: periventricular)&lt;br /&gt;
*Chorioretinitis is the '''most common late finding''' — may appear months to years after birth&lt;br /&gt;
*'''Macrocephaly''' (from hydrocephalus) distinguishes from most other TORCH agents which cause microcephaly&lt;br /&gt;
*Most neonates are asymptomatic at birth; untreated disease leads to progressive neurologic and ocular damage&lt;br /&gt;
*Maternal risk: cat litter, undercooked meat, contaminated soil/water&lt;br /&gt;
&lt;br /&gt;
====Congenital syphilis (''Treponema pallidum'')====&lt;br /&gt;
*'''Early''' (&amp;lt;2 years): hepatosplenomegaly, jaundice, rhinitis ('''snuffles''' — blood-tinged nasal discharge), '''maculopapular rash''' (palms/soles), osteochondritis/periostitis, generalized lymphadenopathy, '''funisitis''' (inflammation of umbilical cord), condylomata lata&lt;br /&gt;
*'''Late''' (&amp;gt;2 years): '''Hutchinson teeth''' (notched, peg-shaped incisors), '''saddle nose''', '''frontal bossing''', '''interstitial keratitis''', '''saber shins''', sensorineural deafness, '''high palatal arch'''&lt;br /&gt;
*'''Hydrops fetalis''' in severe cases&lt;br /&gt;
*Periostitis may be visible on '''skeletal X-rays''' (an important diagnostic clue)&lt;br /&gt;
&lt;br /&gt;
====Rubella (congenital rubella syndrome)====&lt;br /&gt;
*Classic triad: '''sensorineural deafness + cataracts + congenital heart disease''' (especially patent ductus arteriosus, pulmonary artery stenosis)&amp;lt;ref name=&amp;quot;AMBOSS&amp;quot;/&amp;gt;&lt;br /&gt;
*&amp;quot;Blueberry muffin&amp;quot; rash (dermal erythropoiesis)&lt;br /&gt;
*Hepatosplenomegaly, thrombocytopenic purpura&lt;br /&gt;
*Microcephaly, intellectual disability&lt;br /&gt;
*'''Deafness''' is the most common single manifestation&lt;br /&gt;
*Rare in countries with effective vaccination programs; consider in unvaccinated/immigrant populations&lt;br /&gt;
&lt;br /&gt;
====Cytomegalovirus (CMV) — the most common congenital infection====&lt;br /&gt;
*Most common congenital infection worldwide (~0.2-2% of live births)&amp;lt;ref name=&amp;quot;AMBOSS&amp;quot;/&amp;gt;&lt;br /&gt;
*'''~90% are asymptomatic at birth''' — but asymptomatic infants can still develop late-onset hearing loss and developmental delay&lt;br /&gt;
*Symptomatic disease: petechiae, hepatosplenomegaly, jaundice, microcephaly, '''periventricular calcifications''' (compare toxoplasmosis: diffuse), chorioretinitis, seizures&lt;br /&gt;
*'''Sensorineural hearing loss''' is the most important late complication — leading infectious cause of childhood hearing loss worldwide&lt;br /&gt;
*&amp;quot;Blueberry muffin&amp;quot; rash&lt;br /&gt;
&lt;br /&gt;
====Herpes simplex virus (HSV) — the most acutely life-threatening====&lt;br /&gt;
*'''Most EM-critical TORCH infection''' due to rapid progression and high mortality without treatment&amp;lt;ref name=&amp;quot;HSV_JHM&amp;quot;&amp;gt;Schmit M, et al. Clinical progress note: Evaluation and management of neonatal herpes simplex virus disease. ''J Hosp Med''. 2023;18(6):548-555.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Incidence: ~1 in 2,000-3,200 live births in the US&lt;br /&gt;
*~85% acquired '''peripartum''' (during delivery), ~10% postpartum, ~5% in utero&lt;br /&gt;
*'''Three clinical categories:'''&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! Category !! Frequency !! Typical onset !! Key features !! Mortality (with treatment)&lt;br /&gt;
|-&lt;br /&gt;
| '''SEM''' (skin, eyes, mouth) || ~45% || Day 7-14 || Vesicular rash (&amp;gt;80% have vesicles), [[keratoconjunctivitis]], oral ulcers || &amp;lt;1%&lt;br /&gt;
|-&lt;br /&gt;
| '''CNS''' || ~30% || Day 14-21 || Seizures (often focal), irritability, lethargy, poor feeding, bulging fontanelle; vesicles in only ~60% || ~4%&lt;br /&gt;
|-&lt;br /&gt;
| '''Disseminated''' || ~25% || Day 7-14 || Sepsis-like: [[DIC]], [[hepatitis]]/[[liver failure]], pneumonitis, shock; '''CNS involved in up to 75%'''; vesicles in only ~60% || ~30%&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
*'''Critical pitfall:''' vesicular rash is '''absent''' in ~40% of CNS and disseminated disease — '''do not rely on vesicles to suspect HSV'''&amp;lt;ref name=&amp;quot;HSV_JHM&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Fever is often absent at presentation'''&lt;br /&gt;
*'''Any ill neonate &amp;lt;42 days of age with sepsis-like picture, seizures, or liver failure should be empirically treated with acyclovir'''&lt;br /&gt;
&lt;br /&gt;
====Other &amp;quot;O&amp;quot; pathogens====&lt;br /&gt;
*'''Parvovirus B19:''' severe fetal anemia → '''hydrops fetalis''' (nonimmune); aplastic crisis; usually self-limited if live-born; may require intrauterine transfusion&lt;br /&gt;
*'''Varicella (VZV):''' congenital varicella syndrome (limb hypoplasia, cicatricial skin lesions, microcephaly, cortical atrophy, chorioretinitis); very rare with maternal vaccination&lt;br /&gt;
*'''Zika virus:''' microcephaly (often severe), ocular defects, arthrogryposis; epidemic setting; no specific treatment&lt;br /&gt;
*'''HIV:''' usually asymptomatic at birth; testing and prophylaxis per neonatal protocols&lt;br /&gt;
&lt;br /&gt;
==Differential diagnosis==&lt;br /&gt;
===Neonate with the &amp;quot;congenital infection&amp;quot; pattern===&lt;br /&gt;
*'''Other TORCH infections''' (always consider the full panel when one is suspected)&lt;br /&gt;
*[[Neonatal sepsis]] (bacterial — ''E. coli'', GBS)&lt;br /&gt;
*[[Galactosemia]] (may mimic sepsis with liver failure; ''E. coli'' sepsis association)&lt;br /&gt;
*[[Tyrosinemia|Tyrosinemia type 1]] (liver failure + coagulopathy)&lt;br /&gt;
*[[Neonatal hemochromatosis]] (GALD)&lt;br /&gt;
*[[Biliary atresia]] (if jaundice is the presenting sign)&lt;br /&gt;
*Neonatal leukemia/neuroblastoma (&amp;quot;blueberry muffin&amp;quot; appearance)&lt;br /&gt;
*Hemophagocytic lymphohistiocytosis (HLH)&lt;br /&gt;
*Aicardi-Goutières syndrome ('''pseudo-TORCH''' — genetic condition mimicking congenital infection with calcifications + CSF lymphocytosis)&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
===ED workup for suspected congenital infection===&lt;br /&gt;
*'''CBC with differential:''' anemia, thrombocytopenia, atypical lymphocytes, neutropenia&lt;br /&gt;
*'''Hepatic panel:''' AST, ALT (may be markedly elevated in HSV hepatitis), bilirubin (fractionate)&lt;br /&gt;
*'''Coagulation studies:''' PT/INR, fibrinogen (DIC in disseminated HSV)&lt;br /&gt;
*'''Blood glucose:''' hypoglycemia (hepatic failure)&lt;br /&gt;
*'''BMP:''' electrolytes, renal function&lt;br /&gt;
*'''Blood culture''' (to exclude bacterial sepsis)&lt;br /&gt;
*'''Urinalysis and urine culture'''&lt;br /&gt;
*'''Lumbar puncture:''' CSF cell count, protein, glucose, HSV PCR, bacterial culture; HSV PCR on CSF is critical for diagnosis of CNS disease&lt;br /&gt;
*'''ALT specifically:''' markedly elevated ALT is a red flag for disseminated HSV (liver is a primary target organ)&lt;br /&gt;
&lt;br /&gt;
===Pathogen-specific testing (initiate from ED based on clinical suspicion)===&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! Pathogen !! Best diagnostic test !! Key notes&lt;br /&gt;
|-&lt;br /&gt;
| '''HSV''' || '''HSV PCR''' (CSF, blood, surface swabs of mouth/eyes/nasopharynx/vesicles) || Start '''acyclovir empirically''' before results return; also send ALT, DIC labs&lt;br /&gt;
|-&lt;br /&gt;
| '''CMV''' || '''Urine CMV PCR''' or saliva CMV PCR || Must be collected within first '''3 weeks of life''' to distinguish congenital from postnatal infection&lt;br /&gt;
|-&lt;br /&gt;
| '''Toxoplasmosis''' || '''Toxoplasma-specific IgM and IgA''' in infant serum; '''PCR''' || IgG alone reflects maternal antibodies; ophthalmology and neuroimaging needed&lt;br /&gt;
|-&lt;br /&gt;
| '''Syphilis''' || '''RPR/VDRL''' (quantitative) on infant AND mother; '''treponemal test''' (FTA-ABS IgM) || Compare infant to maternal RPR titers; skeletal survey; LP if neurosyphilis suspected&lt;br /&gt;
|-&lt;br /&gt;
| '''Rubella''' || '''Rubella-specific IgM''' in infant serum || Maternal vaccination history is critical; viral culture/PCR of nasopharyngeal secretions&lt;br /&gt;
|-&lt;br /&gt;
| '''Parvovirus B19''' || '''Parvovirus IgM'''; '''PCR''' on blood || Reticulocyte count (aplastic crisis); fetal ultrasound for hydrops&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Imaging===&lt;br /&gt;
*'''Cranial ultrasound''' (neonates): intracranial calcifications, ventriculomegaly, periventricular echogenicity&lt;br /&gt;
*'''CT head:''' more sensitive for calcifications; periventricular (CMV) vs diffuse (toxoplasmosis) distribution pattern&lt;br /&gt;
*'''MRI brain:''' most sensitive for cortical malformations (polymicrogyria in CMV), white matter disease&lt;br /&gt;
*'''Ophthalmologic examination:''' all suspected congenital infections require fundoscopic exam for chorioretinitis&lt;br /&gt;
*'''Skeletal survey:''' periostitis, osteochondritis (congenital syphilis)&lt;br /&gt;
*'''Audiology (ABR):''' arrange for all confirmed congenital infections, especially CMV&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
===HSV — the ED emergency===&lt;br /&gt;
*'''Start IV acyclovir immediately''' in any neonate with suspected HSV — '''do not wait for PCR results'''&amp;lt;ref name=&amp;quot;HSV_JHM&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Dose: acyclovir 20 mg/kg/dose IV every 8 hours''' (= 60 mg/kg/day)&lt;br /&gt;
*'''Duration:'''&lt;br /&gt;
**'''SEM disease: 14 days''' IV&lt;br /&gt;
**'''CNS or disseminated disease: 21 days''' IV&lt;br /&gt;
**Repeat LP with CSF HSV PCR before stopping treatment in CNS disease; '''continue IV acyclovir until CSF PCR is negative'''&amp;lt;ref name=&amp;quot;HSV_NIH&amp;quot;&amp;gt;Herpes Simplex Virus: Pediatric OIs. ''NIH Clinical Guidelines''. 2024.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*After IV course: '''oral acyclovir suppressive therapy''' 300 mg/m²/dose TID for '''6 months''' (reduces cutaneous recurrences and improves neurodevelopmental outcomes in CNS disease)&lt;br /&gt;
*'''Supportive care:''' IV fluids, correct DIC/coagulopathy (FFP, cryoprecipitate, platelets), respiratory support, seizure management, broad-spectrum antibiotics until bacterial sepsis excluded&lt;br /&gt;
*'''Monitor:''' CBC twice weekly (acyclovir-associated neutropenia in ~20%), daily creatinine (nephrotoxicity)&lt;br /&gt;
*'''Ophthalmology consult:''' herpetic keratoconjunctivitis requires topical trifluridine or ganciclovir in addition to systemic therapy&lt;br /&gt;
&lt;br /&gt;
===Congenital syphilis===&lt;br /&gt;
*'''Aqueous penicillin G: 50,000 units/kg/dose IV every 12 hours''' (age &amp;lt;7 days) or '''every 8 hours''' (age ≥7 days) for '''10 days'''&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;br /&gt;
*Alternative: '''Procaine penicillin G 50,000 units/kg IM daily''' for 10 days (if IV not feasible)&lt;br /&gt;
*Normal neonate born to adequately treated mother (≥4 weeks before delivery): single dose '''benzathine penicillin G 50,000 units/kg IM''' may suffice&lt;br /&gt;
*'''No alternative to penicillin''' — penicillin-allergic infants require desensitization&lt;br /&gt;
&lt;br /&gt;
===Congenital toxoplasmosis===&lt;br /&gt;
*'''Pyrimethamine''' (loading dose 2 mg/kg/day for 2 days, then 1 mg/kg/day) + '''sulfadiazine''' (50 mg/kg/dose BID) + '''leucovorin''' (10 mg 3 times weekly) for '''12 months'''&amp;lt;ref name=&amp;quot;CDC_Toxo&amp;quot;&amp;gt;Clinical Care of Toxoplasmosis. ''CDC''. 2024.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Leucovorin (folinic acid) is '''mandatory''' to prevent pyrimethamine-induced bone marrow suppression&lt;br /&gt;
*'''Do NOT substitute folic acid for leucovorin''' — folic acid antagonizes pyrimethamine's therapeutic effect while leucovorin selectively rescues marrow&lt;br /&gt;
*Add '''corticosteroids''' (prednisone 0.5 mg/kg BID) if CSF protein &amp;gt;1 g/dL or vision-threatening chorioretinitis&lt;br /&gt;
*'''Weekly CBC''' while on pyrimethamine (monitor for neutropenia, anemia, thrombocytopenia)&lt;br /&gt;
&lt;br /&gt;
===Congenital CMV===&lt;br /&gt;
*'''Valganciclovir''' (oral) or '''ganciclovir''' (IV) for moderate-to-severe symptomatic congenital CMV&amp;lt;ref name=&amp;quot;AMBOSS&amp;quot;/&amp;gt;&lt;br /&gt;
*Valganciclovir 16 mg/kg/dose BID orally for 6 months is current standard&lt;br /&gt;
*Goal is to preserve hearing and neurodevelopmental outcomes&lt;br /&gt;
*'''Not routinely initiated in the ED''' — refer to infectious disease/neonatology for treatment decisions&lt;br /&gt;
*Monitor for neutropenia, thrombocytopenia, hepatotoxicity&lt;br /&gt;
&lt;br /&gt;
===Congenital rubella===&lt;br /&gt;
*'''No specific antiviral treatment'''&lt;br /&gt;
*Supportive management of cardiac defects, cataracts, hearing loss&lt;br /&gt;
*'''Infectious for up to 1 year''' — isolation precautions; notify public health&lt;br /&gt;
&lt;br /&gt;
===General supportive measures for all congenital infections===&lt;br /&gt;
*Vitamin K (if cholestatic — fat-soluble vitamin malabsorption)&lt;br /&gt;
*Treat [[Neonatal hepatitis|conjugated hyperbilirubinemia]] per workup&lt;br /&gt;
*Nutritional support (MCT-enriched formula if cholestatic)&lt;br /&gt;
*Seizure management&lt;br /&gt;
*Hearing evaluation (ABR) for all&lt;br /&gt;
*Ophthalmologic examination for all&lt;br /&gt;
*Developmental follow-up&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*'''All neonates with suspected congenital infection should be admitted''' — most will require NICU-level care&lt;br /&gt;
*'''HSV:''' start acyclovir in the ED; admit to NICU; infectious disease consultation&lt;br /&gt;
*'''Syphilis with positive RPR or symptomatic:''' admit; start IV penicillin after LP; involve infectious disease&lt;br /&gt;
*'''CMV, toxoplasmosis:''' admit for confirmatory testing, neuroimaging, ophthalmologic evaluation, and treatment initiation&lt;br /&gt;
*'''Well-appearing infant with isolated conjugated hyperbilirubinemia:''' may be evaluated urgently as outpatient (see [[Neonatal hepatitis]]) but ensure TORCH-specific testing is sent and follow-up is reliable&lt;br /&gt;
*'''Notify:''' congenital syphilis and rubella are '''reportable diseases''' — contact public health&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Neonatal hepatitis]]&lt;br /&gt;
*[[Neonatal jaundice]]&lt;br /&gt;
*[[Neonatal HSV]]&lt;br /&gt;
*[[Neonatal sepsis]]&lt;br /&gt;
*[[Biliary atresia]]&lt;br /&gt;
*[[Tyrosinemia]]&lt;br /&gt;
*[[Galactosemia]]&lt;br /&gt;
*[[Sensorineural hearing loss]]&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/books/NBK560528/ StatPearls — TORCH Complex]&lt;br /&gt;
*[https://www.cdc.gov/toxoplasmosis/hcp/clinical-care/index.html CDC — Clinical Care of Toxoplasmosis]&lt;br /&gt;
*[https://pmc.ncbi.nlm.nih.gov/articles/PMC3685871/ PMC — Treatment of HSV Infections in Pediatric Patients]&lt;br /&gt;
*[https://pmc.ncbi.nlm.nih.gov/articles/PMC321459/ Clin Microbiol Rev — Neonatal Herpes Simplex Infection]&lt;br /&gt;
*[https://www.merckmanuals.com/professional/pediatrics/infections-in-neonates/neonatal-herpes-simplex-virus-hsv-infection Merck Manual — Neonatal HSV Infection]&lt;br /&gt;
*[https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/herpes-simplex-virus NIH — Herpes Simplex Virus: Pediatric OIs]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Pediatrics]]&lt;br /&gt;
[[Category:ID]]&lt;/div&gt;</summary>
		<author><name>Ostermayer</name></author>
	</entry>
</feed>